We are live on ! Find out more
CHTP

CHELSEA THERAPEUTICS INT'L LTD
CHTP

Delisted

CHTP was delisted on the 23rd of June, 2014.

6 hedge funds and large institutions have $4.84M invested in CHELSEA THERAPEUTICS INT'L LTD in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $13.8M | Put options by funds: $2.87M

93% less funds holding

Funds holding: 856 (-79)

98% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 81

98% less capital invested

Capital invested by funds: $204M → $4.84M (-$199M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
6
Holders Change
-79
Holders Change %
-92.94%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
Reduced
4
Closed
81
Calls
$13.8M
Puts
$2.87M
Net Calls
+$10.9M
Net Calls Change
+$4.71M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
1
Northern Trust
Illinois
$4.23M -$1.98M -336,177 -34%
WA
2
Whitebox Advisors
Minnesota
$555K +$16.4M +2,777,092 New
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$60K +$4.43M +750,000 New
BBA
4
Baker Bros. Advisors
New York
-$37.3M -6,760,394 Closed
State Street
5
State Street
Massachusetts
-$23M -4,174,872 Closed
GH
6
Green Holdings
Bermuda
-$15.4M -2,795,000 Closed
Millennium Management
7
Millennium Management
New York
-$16.5M -2,793,628 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
-$14.1M -2,559,190 Closed
BIT
9
BlackRock Institutional Trust
California
-$14M -2,529,982 Closed
BFA
10
BlackRock Fund Advisors
California
-$12.1M -2,187,418 Closed
JGC
11
J. Goldman & Co
New York
-$7.51M -1,360,000 Closed
PA
12
Perceptive Advisors
New York
-$7.18M -1,301,639 Closed
VAM
13
Visium Asset Management
New York
-$5.14M -931,134 Closed
VM
14
VHCP Management
New York
-$4.35M -788,370 Closed
GTC
15
Ghost Tree Capital
New York
-$3.31M -600,000 Closed
Bank of New York Mellon
16
Bank of New York Mellon
New York
-$3M -543,123 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
-$2.38M -403,632 Closed
GC
18
Guggenheim Capital
Illinois
-$2.18M -394,786 Closed
Geode Capital Management
19
Geode Capital Management
Massachusetts
-$2.13M -386,040 Closed
TAM
20
THB Asset Management
Connecticut
-$1.89M -341,920 Closed
Group One Trading
21
Group One Trading
Illinois
-$1.98M -334,666 Closed
TCIM
22
TIAA CREF Investment Management
New York
-$1.75M -317,319 Closed
EI
23
EAM Investors
California
-$1.72M -311,422 Closed
Invesco
24
Invesco
Georgia
-$1.51M -274,193 Closed
Ameriprise
25
Ameriprise
Minnesota
-$1.6M -271,878 -100%

CHTP Hedge Fund Activity: Q2 2014 in Review

6 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q2 2014, worth a combined $4.84M — down 98% from $204M a quarter earlier.

Sellers outnumbered buyers: 81 funds closed out of CHTP and 2 opened new positions — a net loss of 79 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Whitebox Advisors, opening a new position worth an estimated $16.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $37.3M sold.

  • 6 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q2 2014, down from 85 in Q1 2014.
  • Funds reported $4.84M of CHELSEA THERAPEUTICS INT'L LTD stock for Q2 2014, down 98% quarter-over-quarter.
  • 2 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q2 2014 and 81 closed out, a net change of -79 holders.
  • The largest CHELSEA THERAPEUTICS INT'L LTD buyer in Q2 2014 was Whitebox Advisors, an estimated $16.4M added.
  • The largest CHELSEA THERAPEUTICS INT'L LTD seller in Q2 2014 was Baker Bros. Advisors, an estimated $37.3M sold.

Based on aggregated 13F filings for Q2 2014.